POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml

7680675940011 CH-67594 J02AC04 08.06.0.

Reimbursement limitations:

NOXAFIL2

La prophylaxie chez des patients à risque élevé (voir 1a et 1b) peut être prescrit …

POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml
POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml
POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml
1 / 3
google

Details

Product number
6759401
CPT
-
Packaging group
105
Unit
ml
Composition
posaconazolum 200 mg, polysorbatum 80, xanthani gummi, natrii benzoas 10 mg, acidum citricum monohydricum, natrii citras dihydricus, glycerolum, glucosum liquidum 1750 mg, E 171, simeticonum, polysorbatum 65, methylcellulosum, macrogoli stearas, mono/diglycerida, E 200, E 210 0.045 mg, acidum sulfuricum, aromatica (Kirschen) cum propylenglycolum 14.35 mg, aqua purificata ad suspensionem pro 5 ml corresp. natrium 3.4 mg.

Articles (1)

Posaconazol Devatis 40mg/ml, Suspension zum Einnehmen
suspension
105
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/06/2025
Patient information leaflet
Français
30/06/2025
Patient information leaflet
Italien
30/06/2025
Professional SmPC
Allemand
30/06/2025
Professional SmPC
Français
30/06/2025
Professional SmPC
Italien
30/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1750.0 MG Substance HBESI
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
0.045 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
14.35 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
3.4 MG Substance HBESI

Reimbursement information

Public price
CHF 574.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2021

Authorization holder

Devatis AG

6330 Cham

Authorization information

Swissmedic authorization number
67594
Drug name
Posaconazol Devatis, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
J02AC04
Authorization status
Z
Dispensation category
B
First authorization
06/08/2020
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Pilzinfektionen

Packaging details

Description (FR)
POSACONAZOLE Devatis susp 40 mg/ml buvable 105 ml
Description (DE)
POSACONAZOL Devatis Susp 40 mg/ml z Einnehm 105 ml
Market launch
06/08/2020
Narcotic (BTM)
No

Original drug

Noxafil, Konzentrat zur Herstellung einer Infusionslösung
CHF 456.15
View original